10-94030912-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016341.4(PLCE1):​c.-135G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 850,334 control chromosomes in the GnomAD database, including 35,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 8116 hom., cov: 32)
Exomes 𝑓: 0.27 ( 27797 hom. )

Consequence

PLCE1
NM_016341.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.140

Publications

10 publications found
Variant links:
Genes affected
PLCE1 (HGNC:17175): (phospholipase C epsilon 1) This gene encodes a phospholipase enzyme that catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate to generate two second messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). These second messengers subsequently regulate various processes affecting cell growth, differentiation, and gene expression. This enzyme is regulated by small monomeric GTPases of the Ras and Rho families and by heterotrimeric G proteins. In addition to its phospholipase C catalytic activity, this enzyme has an N-terminal domain with guanine nucleotide exchange (GEF) activity. Mutations in this gene cause early-onset nephrotic syndrome; characterized by proteinuria, edema, and diffuse mesangial sclerosis or focal and segmental glomerulosclerosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Sep 2009]
PLCE1 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 10-94030912-G-A is Benign according to our data. Variant chr10-94030912-G-A is described in ClinVar as [Benign]. Clinvar id is 301676.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCE1NM_016341.4 linkc.-135G>A 5_prime_UTR_variant Exon 2 of 33 ENST00000371380.8 NP_057425.3 Q9P212-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCE1ENST00000371380.8 linkc.-135G>A 5_prime_UTR_variant Exon 2 of 33 1 NM_016341.4 ENSP00000360431.2 Q9P212-1

Frequencies

GnomAD3 genomes
AF:
0.314
AC:
47769
AN:
151894
Hom.:
8111
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.445
Gnomad AMI
AF:
0.224
Gnomad AMR
AF:
0.222
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.316
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.254
Gnomad OTH
AF:
0.283
GnomAD4 exome
AF:
0.274
AC:
191034
AN:
698322
Hom.:
27797
Cov.:
9
AF XY:
0.275
AC XY:
102490
AN XY:
373362
show subpopulations
African (AFR)
AF:
0.437
AC:
7804
AN:
17856
American (AMR)
AF:
0.156
AC:
6226
AN:
39894
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
4967
AN:
20356
East Asian (EAS)
AF:
0.467
AC:
16274
AN:
34816
South Asian (SAS)
AF:
0.302
AC:
19788
AN:
65424
European-Finnish (FIN)
AF:
0.285
AC:
13458
AN:
47212
Middle Eastern (MID)
AF:
0.245
AC:
645
AN:
2638
European-Non Finnish (NFE)
AF:
0.258
AC:
112182
AN:
435206
Other (OTH)
AF:
0.277
AC:
9690
AN:
34920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
6680
13360
20040
26720
33400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1850
3700
5550
7400
9250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.314
AC:
47790
AN:
152012
Hom.:
8116
Cov.:
32
AF XY:
0.316
AC XY:
23485
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.444
AC:
18416
AN:
41442
American (AMR)
AF:
0.222
AC:
3384
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
816
AN:
3464
East Asian (EAS)
AF:
0.437
AC:
2263
AN:
5174
South Asian (SAS)
AF:
0.315
AC:
1519
AN:
4824
European-Finnish (FIN)
AF:
0.306
AC:
3233
AN:
10570
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.254
AC:
17283
AN:
67960
Other (OTH)
AF:
0.283
AC:
599
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1627
3253
4880
6506
8133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.270
Hom.:
7460
Bravo
AF:
0.313
Asia WGS
AF:
0.362
AC:
1258
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrotic syndrome, type 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.7
DANN
Benign
0.54
PhyloP100
-0.14
PromoterAI
-0.0090
Neutral
Mutation Taster
=296/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10882386; hg19: chr10-95790669; COSMIC: COSV53373273; API